Haydale Graphene Industries : Interim Results Presentation 2023

Investor Presentation

Interim Results

6 months to December 2022

Keith Broadbent

Chief Executive Officer

Mark Chapman

Chief Financial Officer

March 2023

Period Highlights

• Group Revenues increased by 50% to £1.78 million (H1 FY22 £1.19 million)
• Sales of biomedical inks achieved in Europe and advanced trials being conducted which include electronic blood glucose reader compatibility tests
• One tonne of functionalised powder supplied to leading cycle tyre manufacturer Vittoria Spa - more orders anticipated in the current period.
• Developed a prototype underfloor heating solution - potential to replace high voltage electric or water-basedfloor heating systems in residential buildings.
• As expected, strong growth in US revenues with rebound in Silicon Carbide powder sales and growing blanks and finished tools sales.

2

Haydale - Our USP

• Haydale has solved the Graphene Challenge
• • A potentially inert substance made usable through functionalisation
• Patented HDPlas™ functionalisation process
• • Greener, cleaner and more tunable 'powder in - powder out'
  • Patent protected in key countries, significant in house 'know how'
• Right time to focus on Graphene and other nanomaterials
• • Fourth industrial revolution - market forecast to grow exponentially - Global nanomaterials market currently worth US$9.68 billion1.
• Consistent process that supports industrial scale
• • Consistency is our key to meeting customers quality requirements
• Capacity to produce on an industrial scale
• • Installed production capacity sufficient for breakeven and beyond
  • Further Scale up can be achieved with a RoI of less than 12 months

1. Precedence Research - 'Nanomaterials Market Size, Growth, Trends - Report 2022-2030

Our Priorities

Secure		Optimise
short to
capacity to
medium
		meet
term
		volume
commercial
	demands
revenue
Upgrade
operational	Extend our
capability
	technology
- satisfy
		advantage
large
customers
Provide a			Create
significant		options at
return to			our US
investors		operation

Within this framework, the company is focusing on 5 key products

• Biomedical Inks
• Heating Products
• Security Inks
• Elastomers (Tyres/shoes)
• Paints and Coatings

assessed to provide short to medium term profit and cashflow opportunities.

4

Key Product Update

Key Benefit	Status

Target Customer

Update

Biomedical lInks
Security Inks	Conductive/
Shoes/ Tyres	Elastomers
Customers	Nano Material

Cost effective, non-invasive monitoring of chronic conditions and detecting other diseases

Cost effective and environmentally friendlier solution to reduce metallic content of security tags

Improved rubber compounds - increased tear strength, improved slip resistance and weight reduction

Functionalising customers nanomaterials to improve performance

Advanced testing with a number of customers in Europe and East Asia

Commercial Project with leading supplier of RFID solutions in progress

One tonne delivered to Vittoria. Further orders to follow.

Several large suppliers engaged to enhance the performance of their raw material offering

Major Market - Glucose monitoring companies - potential for other diseases

Project Sponsor

Vittoria

Other tyre companies

Footwear companies

Graphene suppliers

Boron Nitride suppliers

Ink now developed. First sales achieved, challenges to commercialization being overcome

Project on plan

First volume sales delivered, focussing on further customer penetration

Developing revenue stream.

5